Please Wait.....
Report
Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-11-02 I 147 Pages I IMARC Group
The global vaccine contract manufacturing market reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.3% during 2022-2028.
Vaccine contract manufacturing refers to the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous services, including pre-formulation work, formulation development, method development, stability studies, pre-clinical activities, registration batches and commercial manufacturing. Apart from this, they provide expertise and innovative technologies to expand the production chain of pharmaceutical companies. At present, the demand for outsourcing vaccine manufacturing activities is escalating worldwide on account of reduced development costs and complex production protocols.
Vaccination plays a pivotal role in improving human as well as veterinary health. It reduces the need for antibiotics and prevents diseases. The increasing awareness about vaccination and numerous associated benefits, such as protection from severe illnesses and infectious diseases, is catalyzing the demand for immunization programs and inoculations. This, in confluence with understanding the complexity of capital requirement for production, has led the leading pharmaceutical companies to outsource vaccine manufacturing. Apart from this, the lack of equipment and skilled labor for vaccine production in low-resource countries is also contributing to the global vaccine contract manufacturing market growth. Moreover, technological advancements, including the introduction of expression systems like the EB66 and GPEx and cell culture media platforms, are supporting the market growth. Furthermore, the alarmingly growing cases of coronavirus disease (COVID-19) in numerous countries have propelled the vaccine developers to sign outsourcing agreements with CMOs. This is creating a favorable outlook for the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine contract manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, workflow and application.
Breakup by Vaccine Type:
Attenuated
Inactivated
Subunit-based
Toxoid-based
DNA-based
Breakup by Workflow:
Downstream
Fill and Finish Operations
Analytical and QC Studies
Packaging
Upstream
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression Systems
Others
Breakup by Application:
Human Use
Veterinary
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cobra Biologics Limited (Charles River Laboratories International Inc.), Cytovance Biologics Inc. (Hepalink USA Inc.), Fujifilm Holdings Corporation, ICON plc, IDT Biologika GmbH, Lonza Group AG, Merck KGaA, Pharmaceutical Product Development LLC and PRA Health Sciences Inc.
Key Questions Answered in This Report:
How has the global vaccine contract manufacturing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global vaccine contract manufacturing market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the workflow?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global vaccine contract manufacturing market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 Executive Summary
4 Introduction
4.1Overview
4.2Key Industry Trends
5 Global Vaccine Contract Manufacturing Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 Market Breakup by Vaccine Type
6.1Attenuated
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Inactivated
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Subunit-based
6.3.1 Market Trends
6.3.2 Market Forecast
6.4Toxoid-based
6.4.1 Market Trends
6.4.2 Market Forecast
6.5DNA-based
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Workflow
7.1Downstream
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Fill and Finish Operations
7.1.2.2 Analytical and QC studies
7.1.2.3 Packaging
7.1.3 Market Forecast
7.2Upstream
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Mammalian Expression Systems
7.2.2.2 Bacterial Expression Systems
7.2.2.3 Yeast Expression Systems
7.2.2.4 Baculovirus/Insect Expression Systems
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Application
8.1Human Use
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Veterinary
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1Ajinomoto Co. Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Albany Molecular Research Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3Catalent Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4Cobra Biologics Limited (Charles River Laboratories International Inc.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5Cytovance Biologics Inc. (Hepalink USA Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6Fujifilm Holdings Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7ICON plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8IDT Biologika GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9Lonza Group AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10Merck KGaA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11Pharmaceutical Product Development LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12PRA Health Sciences Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2022
Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2022
Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2022
Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis
Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million US$), 2023-2028
Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
Table 7: Global: Vaccine Contract Manufacturing Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security